PROTECT DX Trademark

Trademark Overview

On Friday, October 15, 2021, a trademark application was filed for PROTECT DX with the United States Patent and Trademark Office. The USPTO has given the PROTECT DX trademark a serial number of 97077510. The federal status of this trademark filing is SECOND EXTENSION - GRANTED as of Thursday, June 13, 2024. This trademark is owned by Cutaneous Neurodiagnostics, LLC. The PROTECT DX trademark is filed in the Medical & Beauty Services & Agricultural Services category with the following description:

Medical testing for neurodegenerative disorders and other diagnostic or treatment purposes; Providing collected and analyzed medical information for diagnostic and treatment purposes for neurodegenerative disorders; Health assessment services, namely, performing quantitative neuropathological assessments of sensory, motor, and/or autonomic nerve fiber density; Health assessment services, namely, providing a pathological test for a diagnosis of synucleinopathy; Diagnostic services, namely, medical diagnostic testing for neurodegenerative disorders; Medical diagnostic testing, monitoring and reporting services; Providing medical data and information to healthcare professionals; Providing medical information to medical professionals in the form of reports in the field of neurological disorders
protect dx

General Information

Serial Number97077510
Word MarkPROTECT DX
Filing DateFriday, October 15, 2021
Status731 - SECOND EXTENSION - GRANTED
Status DateThursday, June 13, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, June 27, 2023

Trademark Statements

Pseudo MarkPROTECT DIAGNOSIS
Goods and ServicesMedical testing for neurodegenerative disorders and other diagnostic or treatment purposes; Providing collected and analyzed medical information for diagnostic and treatment purposes for neurodegenerative disorders; Health assessment services, namely, performing quantitative neuropathological assessments of sensory, motor, and/or autonomic nerve fiber density; Health assessment services, namely, providing a pathological test for a diagnosis of synucleinopathy; Diagnostic services, namely, medical diagnostic testing for neurodegenerative disorders; Medical diagnostic testing, monitoring and reporting services; Providing medical data and information to healthcare professionals; Providing medical information to medical professionals in the form of reports in the field of neurological disorders
NOT AVAILABLE"DX"

Classification Information

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, November 4, 2021
Primary Code044
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameCND LIFE SCIENCES, INC
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSCOTTSDALE, AZ 85258
Party NameCND LIFE SCIENCES, INC
Party Type11 - New Owner Before Publication
Legal Entity Type03 - Corporation
AddressSCOTTSDALE, AZ 85258
Party NameCutaneous Neurodiagnostics, LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressPhoenix, AZ 85018

Trademark Events

Event DateEvent Description
Tuesday, October 19, 2021NEW APPLICATION ENTERED
Thursday, November 4, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, April 11, 2022ASSIGNED TO EXAMINER
Wednesday, April 13, 2022NON-FINAL ACTION WRITTEN
Wednesday, April 13, 2022NON-FINAL ACTION E-MAILED
Wednesday, April 13, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, May 27, 2022TEAS CHANGE OF OWNER ADDRESS RECEIVED
Friday, May 27, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, May 27, 2022APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, October 12, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, December 1, 2022ASSIGNED TO LIE
Friday, December 2, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, December 2, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, December 23, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, December 23, 2022NON-FINAL ACTION WRITTEN
Friday, December 23, 2022NON-FINAL ACTION E-MAILED
Friday, December 23, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, December 28, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, December 28, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, January 20, 2023NON-FINAL ACTION WRITTEN
Friday, January 20, 2023NON-FINAL ACTION E-MAILED
Friday, January 20, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, April 20, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, April 24, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, April 24, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, May 3, 2023AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Tuesday, May 16, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, May 23, 2023LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, June 7, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, June 27, 2023PUBLISHED FOR OPPOSITION
Tuesday, June 27, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, August 22, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Friday, December 1, 2023SOU TEAS EXTENSION RECEIVED
Friday, December 1, 2023SOU EXTENSION 1 FILED
Friday, December 1, 2023SOU EXTENSION 1 GRANTED
Tuesday, December 5, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, June 13, 2024SOU TEAS EXTENSION RECEIVED
Thursday, June 13, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, June 13, 2024SOU EXTENSION 2 GRANTED
Thursday, June 13, 2024SOU EXTENSION 2 FILED

Related Keywords

protect medical diagnostic providing services disorders namely information neurodegenerative testing assessment